Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NCT01011010 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: doxorubicin hydrochloride
DRUG: mitomycin C
DRUG: sorafenib tosylate
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]